Lung Diseases, Obstructive: Clinical Trials

10,591 trials for Lung Diseases, Obstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6838 completed, 1387 unknown, 789 recruiting, 611 terminated. 3464 Not applicable, 1450 Phase 2, 1293 Phase 3, 937 Phase 4, 820 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3464Completed 2051, Unknown 554, Recruiting 317, Terminated 171, Not yet recruiting 160, Withdrawn 90, Active not recruiting 88, Enrolling by invitation 22, Suspended 11
Phase 21450Completed 982, Terminated 150, Recruiting 95, Unknown 91, Withdrawn 67, Active not recruiting 35, Not yet recruiting 22, Enrolling by invitation 4, Suspended 4
Phase 31293Completed 984, Terminated 81, Unknown 80, Recruiting 66, Withdrawn 43, Not yet recruiting 18, Active not recruiting 17, Enrolling by invitation 3, Suspended 1
Phase 4937Completed 643, Unknown 114, Terminated 67, Withdrawn 43, Recruiting 34, Not yet recruiting 18, Active not recruiting 15, Enrolling by invitation 3
Phase 1820Completed 614, Terminated 62, Recruiting 41, Unknown 38, Withdrawn 27, Active not recruiting 20, Not yet recruiting 14, Suspended 4
Early Phase 165Completed 35, Unknown 11, Terminated 6, Recruiting 4, Active not recruiting 3, Withdrawn 3, Enrolling by invitation 2, Not yet recruiting 1

Follow Lung Diseases, Obstructive: new trials by email Literature Review of Lung Diseases, Obstructive trials Research Report on Lung Diseases, Obstructive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management
VC-OPTIONS - Chronic Obstructive Pulmonary Disease
Not applicableNot yet recruitingVA Office of Research and Development402027-09-022026-09-29
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Remote Management, Remote Monitoring Only - COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD
Not applicableNot yet recruitingSir Run Run Shaw Hospital2362027-08-012026-08-06
RSV Vaccination to Reduce Recurrent AECOPD
RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV
Phase 4Not yet recruitingChinese University of Hong Kong3202027-07-012026-04-13
cfMSC Stem Cell Therapy Targeting COPD
clonal fetal MSCs - Chronic Obstructive Pulmonary Disease (COPD)
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-11-02
The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease
Verducatib, Placebo matching verducatib - Chronic Obstructive Pulmonary Disease
Phase 3Not yet recruitingBoehringer Ingelheim18002027-03-102026-11-10
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function
Phase 2Not yet recruitingForesee Pharmaceuticals Co., Ltd.1352027-03-012026-07-20
Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
Biospecimen Collection, Mindfulness Relaxation, Survey Administration - Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm
Not applicableRecruitingCity of Hope Medical Center172027-03-012026-10-16
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
treprostinil SMI (treprostinil inhalation spray) - Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Phase 2 / Phase 3Not yet recruitingUnited Therapeutics4002027-03-012026-11-06
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype
Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation
Phase 4Not yet recruitingSidra Aziz702027-02-012026-08-31
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
Metformin - Chronic Obstructive Pulmonary Disease (COPD)
Phase 1Not yet recruitingDuke University452027-02-012026-11-03
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg, Comparator - Trimbow® - Chronic Obstructive Pulmonary Disease
Phase 3Not yet recruitingEurofarma Laboratorios S.A.12522027-01-302026-10-26
Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)
Budesonide/Glycopyrronium/Formoterol fumarate metered dose inhaler - Asthma, Uncontrolled Asthma
Not yet recruitingAstraZeneca2002027-01-292026-11-12
Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies
Initial assesment interwiew, Intake Interview with the Patient - Severe Asthma
Not yet recruitingUniversity Hospital, Angers202027-01-042026-10-02
Repeat Treatment With Metered Cryospray in Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Metered cryospray (MCS) - COPD (Chronic Obstructive Pulmonary Disease), Chronic Bronchitis
Not applicableNot yet recruitingCSA Medical, Inc.102027-01-022026-10-05
Pulmonary Rehabilitation Frequency in COPD Patients
Pulmonary Rehabilitation - COPD, COPD (Chronic Obstructive Pulmonary Disease)
Not applicableNot yet recruitingHospital Universitario Fundación Alcorcón1582027-01-012026-05-08
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Slow Release DHEA, Placebo - Asthma
Phase 2Not yet recruitingIndiana University302027-01-012026-02-27
A Study of the Effect of a Nurse Navigator Program on High Risk Patients
Nurse Navigator Program - Patient Readmission, Arthroplasty, Replacement, Knee
Not applicableNot yet recruitingMayo Clinic3002027-01-012026-03-19
Nebulized Ketamine for Severe Asthma Attacks in Children
Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma
Phase 2Not yet recruitingSultan Qaboos University602027-01-012026-07-27

Showing 20 of 10591. Sign in to see all of them.

Narrower conditions

Pulmonary Disease, Chronic Obstructive (5343)  ·  Asthma (4474)  ·  Bronchiolitis Obliterans Syndrome (707)  ·  Lung Diseases (346)  ·  Emphysema (301)  ·  Dyspnea (297)  ·  Motor Activity (287)  ·  Bronchiolitis (263)  ·  Heart Failure (223)  ·  Bronchitis, Chronic (201)  ·  Hypersensitivity (191)  ·  Bronchitis (146)  ·  Diabetes Mellitus (143)  ·  Inflammation (137)

Broader conditions

Respiratory Tract Diseases (10487)  ·  Lung Diseases (10245)  ·  Pathological Conditions, Signs and Symptoms (6258)  ·  Bronchial Diseases (5790)  ·  Pathologic Processes (5779)  ·  Disease Attributes (5566)  ·  Chronic Disease (5457)  ·  Immune System Diseases (5226)  ·  Hypersensitivity, Immediate (4485)  ·  Respiratory Hypersensitivity (4458)  ·  Hypersensitivity (4327)  ·  Bronchitis (1228)  ·  Infections (970)  ·  Signs and Symptoms (964)

Interventions

Tiotropium Bromide (274)  ·  Formoterol Fumarate (236)  ·  Fluticasone (234)  ·  Budesonide (230)  ·  Albuterol (227)  ·  Salmeterol Xinafoate (172)  ·  montelukast (153)  ·  Fluticasone-Salmeterol Drug Combination (134)  ·  Budesonide, Formoterol Fumarate Drug Combination (107)  ·  Exercise (105)  ·  Beclomethasone (97)  ·  Glycopyrrolate (91)  ·  indacaterol (90)  ·  Standard of Care (71)  ·  Omalizumab (70)

Sponsors

AstraZeneca (530)  ·  GlaxoSmithKline (523)  ·  Boehringer Ingelheim (293)  ·  Novartis Pharmaceuticals (178)  ·  Chiesi Farmaceutici S.p.A. (117)  ·  National Heart, Lung, and Blood Institute (NHLBI) (102)  ·  Riphah International University (91)  ·  Imperial College London (85)  ·  Organon and Co (66)  ·  Assistance Publique - Hôpitaux de Paris (64)  ·  Sanofi (62)  ·  Laval University (57)  ·  Pfizer (56)  ·  Johns Hopkins University (54)  ·  Brigham and Women's Hospital (52)

Countries

United States (3156)  ·  United Kingdom (1135)  ·  Germany (955)  ·  Canada (872)  ·  France (785)  ·  China (649)  ·  Spain (576)  ·  Italy (502)  ·  Poland (447)  ·  Netherlands (438)  ·  Turkey (Türkiye) (403)  ·  Belgium (379)  ·  Denmark (364)  ·  South Korea (324)  ·  Russia (311)

Top investigators

Louis-Philippe Boulet, MD (21)  ·  Dave Singh, MD (19)  ·  Esther Garcia, MD (19)

Results publications

PMID 36472162, PMID 33511633, PMID 27881132, PMID 34495549, PMID 37010196, PMID 32943047, PMID 35815359, PMID 42149813, PMID 37542951, PMID 39393433, PMID 31319851, PMID 29400693, PMID 35691614, PMID 42551404, PMID 17507545, PMID 24314123, PMID 33217063, PMID 35514131, PMID 38127464, PMID 39423760, PMID 12091180, PMID 19720809, PMID 24127811, PMID 26704701, PMID 30954640, PMID 32816215, PMID 33124005, PMID 33305842, PMID 10377201, PMID 16055882, PMID 1759018, PMID 17951621, PMID 20102307, PMID 22329608, PMID 23497334, PMID 24184147, PMID 25066329, PMID 25359355, PMID 25496316, PMID 25918120, PMID 28065396, PMID 28419462, PMID 29174062, PMID 29536781, PMID 30077810, PMID 32180164, PMID 32462607, PMID 32671684, PMID 32848381, PMID 33152467

NIH funding

2015 (52), 2009 (47), 2017 (43), 2014 (40), 2016 (39), 2023 (38), 2018 (36), 2019 (32), 2025 (30), 2008 (28), U10HL098115 (8), 2005 (7), U10HL074212 (6), P01HL107202 (5), R01HL082480 (5)